Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-1997 | 12-1996 | 09-1996 | 06-1996 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 7,330 | 7,330 | 760 | 770 |
| Marketable Securities | 0 | 0 | 6,490 | 6,420 |
| Receivables | 1 | 1 | 2 | 2 |
| Other current assets | -1 | -1 | 8 | -2 |
| TOTAL | $7,330 | $7,330 | $7,260 | $7,190 |
| Non-Current Assets | ||||
| Other Non-Current Assets | 8 | 8 | 0 | 0 |
| TOTAL | $8 | $8 | $N/A | $N/A |
| Total Assets | $7,340 | $7,340 | $7,260 | $7,190 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accrued Expenses | 0 | 4 | 0 | 0 |
| TOTAL | $30 | $80 | $50 | $20 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 7,300 | 7,260 | 0 | 0 |
| TOTAL | $7,300 | $7,260 | $N/A | $N/A |
| Total Liabilities | $7,340 | $7,340 | $50 | $20 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | 0 | 50 | 20 |
| Other shareholders' equity | 0 | 0 | 40 | 30 |
| TOTAL | $0 | $0 | $7,210 | $7,170 |
| Total Liabilities And Equity | $7,340 | $7,340 | $7,260 | $7,190 |